News und Analysen
Schwab Announces Its Winter Business Update
The Charles Schwab Corporation announced today that it has scheduled a Winter Business Update for institutional investors on Wednesday, January 21st. This Update, which will be held via live public
Partners Group’s announcement of AuM as of 31 December 2025
Marsh McLennan’s Mercer to Invest in a Bespoke Long-Term Asset Fund for Private Markets With an Initial Commitment of £350 Million
Mercer, a business of Marsh McLennan (NYSE: MMC) and a global leader in helping clients realise their investment objectives, shape the future of work and enhance health and retirement outcomes for
Swiss Life: change on the Board of Directors in the coming year
Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Fifth Third Announces Changes to its Board of Directors
Fifth Third (Nasdaq: FITB) today announced that Thomas H. (Hal) Harvey will retire from its Board of Directors, and Priscilla Almodovar will join the Board, effective January 7, 2026.
“Hal’s
Turkiye Garanti Bankasi A.S.: Changes in Top Management
Fifth Third Bank to Decrease Prime Lending Rate to 6.75%
Fifth Third Bank, National Association (Nasdaq: FITB) today announced it will decrease its prime lending rate to 6.75%, effective immediately.
The rate was last changed on October 29, 2025, when
Nebius debuts the Robotics & Physical AI Awards and Summit to support next-generation startups with $1.5 Million in compute credits
Kinder Morgan Announces 2026 Financial Expectations
Kinder Morgan, Inc. (NYSE: KMI) today announced its preliminary 2026 financial projections. “We expect approximately 4% growth in Adjusted EBITDA and 8% growth in Adjusted EPS compared to the 2025
Turkiye Garanti Bankasi A.S.: Announcement regarding our Bank’s Corporate Governance Compliance Rating
Turkiye Garanti Bankasi A.S.: Announcement regarding Syndicated Loan Agreement
Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome
Bayer announced today initiation of a Phase IIa clinical trial with BAY 3401016, an investigational monoclonal antibody with potential to block a protein called Semaphorin 3A (Sema3A), which is
Coinbase to Participate in 53rd Annual Nasdaq London Investor Conference
Coinbase Global, Inc. announced today that Alesia Haas, Chief Financial Officer, will participate in a fireside chat at the 53rd Annual Nasdaq London Investor Conference on Wednesday, December 10
RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints
Bayer, a global leader in radiology, today revealed results from the QUANTI Pediatric study, adding to the pharmacokinetic, safety and efficacy data of the investigational low-dose MRI
Hardman & Co Research on NB Private Equity Partners (NBPE): 2025 CMD good returns from low risk PE model
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
.jpg?locale=de)
Coinbase to Participate in Goldman Sachs 2025 Financial Services Conference
Coinbase Global, Inc. announced today that Alesia Haas, Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs 2025 Financial Services Conference on Tuesday, December 9
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia
Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing intrauterine system Mirena® for the
Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations
Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast
Turkiye Garanti Bankasi A.S.: Dates on which the Trading Lines of Investment Institution Warrants Will Be Closed Due to Foreign Public Holidays
Ørsted and ESB joint venture secures the provisional rights to develop the Tonn Nua site in Irish offshore wind auction
Carmax Announces Third Quarter Conference Call
CarMax, Inc. (NYSE:KMX) will report its financial results for the third quarter ended November 30, 2025 before the market opens on December 18, 2025, and it will host a conference call with
Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
Chow Tai Fook Jewellery Reports Solid Recovery Trajectory in 1HFY2026 Underpinned by Strong Margins and Steady Progress in Brand Transformation